Annual Working Capital
$945.37 M
-$160.91 M-14.55%
December 31, 2021
Summary
- As of February 9, 2025, TPTX annual working capital is $945.37 million, with the most recent change of -$160.91 million (-14.55%) on December 31, 2021.
- During the last 3 years, TPTX annual working capital has risen by +$849.17 million (+882.71%).
Performance
TPTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$782.24 M
-$99.62 M-11.30%
June 30, 2022
Summary
- As of February 9, 2025, TPTX quarterly working capital is $782.24 million, with the most recent change of -$99.62 million (-11.30%) on June 30, 2022.
- Over the past year, TPTX quarterly working capital has stayed the same.
Performance
TPTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TPTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.6% | 0.0% |
| 3 y3 years | +882.7% | 0.0% |
| 5 y5 years | +2200.8% | 0.0% |
TPTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -17.3% | at low |
| 5 y | 5-year | -14.5% | -57.6% | -29.3% | -51.6% |
| alltime | all time | -14.5% | -95.7% | -29.3% | -89.4% |
Turning Point Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $782.24 M(-11.3%) |
| Mar 2022 | - | $881.87 M(-6.7%) |
| Dec 2021 | $945.37 M(-14.5%) | $945.37 M(-6.2%) |
| Sep 2021 | - | $1.01 B(-4.8%) |
| Jun 2021 | - | $1.06 B(-3.5%) |
| Mar 2021 | - | $1.10 B(-0.8%) |
| Dec 2020 | $1.11 B | $1.11 B(+58.5%) |
| Sep 2020 | - | $697.91 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $707.43 M(+87.0%) |
| Mar 2020 | - | $378.24 M(-5.7%) |
| Dec 2019 | $400.92 M(+316.7%) | $400.92 M(-4.0%) |
| Sep 2019 | - | $417.65 M(+68.9%) |
| Jun 2019 | - | $247.28 M(+197.1%) |
| Mar 2019 | - | $83.24 M(-13.5%) |
| Dec 2018 | $96.20 M(+134.1%) | $96.20 M |
| Dec 2017 | $41.09 M | - |
FAQ
- What is Turning Point Therapeutics annual working capital?
- What is the all time high annual working capital for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual working capital year-on-year change?
- What is Turning Point Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly working capital year-on-year change?
What is Turning Point Therapeutics annual working capital?
The current annual working capital of TPTX is $945.37 M
What is the all time high annual working capital for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual working capital is $1.11 B
What is Turning Point Therapeutics annual working capital year-on-year change?
Over the past year, TPTX annual working capital has changed by -$160.91 M (-14.55%)
What is Turning Point Therapeutics quarterly working capital?
The current quarterly working capital of TPTX is $782.24 M
What is the all time high quarterly working capital for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly working capital is $1.11 B
What is Turning Point Therapeutics quarterly working capital year-on-year change?
Over the past year, TPTX quarterly working capital has changed by $0.00 (0.00%)